Lexington-Fayette, Kentucky 2021-09-13 14:31:25 –
Moderna states that it is developing a single vaccine that may act as a COVID-19 booster shot and a flu shot.
so Press release On Thursday, advertising its fifth annual R & D Day, Moderna said it is developing several new mRNA vaccines, including a combination of influenza vaccination and a COVID-19 vaccine booster. ..
The company didn’t say how far Shot was developed or when Phase 1 testing could begin.
“We are proud of the progress the Moderna team has made in advancing the best-in-class mRNA pipeline while addressing the global COVID-19 pandemic,” said Moderna CEO Stéphane Bancel. “We believe our mRNA platform can solve the world’s largest health challenges, from diseases affecting millions to ultra-rare diseases affecting dozens to personalized medicines at the individual level. increase.”
This announcement will be made when the FDA is considering granting approval for Moderna’s COVID-19 booster shots. In August, the White House recommended that all fully vaccinated Americans look for boosters from the week of September 20th. However, reports show FDA approval for Modana’s booster shots. May not come until early October..
In the same press release, Moderna has developed four vaccine candidates that act as boosters for variants of current concern, including delta variants.